Document is current
Any future updates will be listed below
-
Authors
Wang, Joy https://orcid.org/0009-0003-0065-8136
Kedarisetti, Pradyumna https://orcid.org/0000-0002-2522-5535
McAlister, Ewan A. https://orcid.org/0009-0000-7466-8722
Mallay, Matthew G.
Woodacre, Jeffrey K.
Adam, Benjamin A. https://orcid.org/0000-0003-1908-1739
Maglantay, Remegio J.
Jovel, Juan
Wuest, Frank R.
Brown, Jeremy A.
Zemp, Roger J. https://orcid.org/0000-0001-6802-5624
-
Funding
Funding for this research was provided by:
Alberta Cancer Foundation (ACF JFMRP 27587)
Canadian Cancer Society Research Institute (CCS 702032)
Government of Alberta Cancer Research for Screening and Prevention Fund
- License Information
-
More Information
Article History
Received: 11 April 2025
Accepted: 14 April 2026
First Online: 2 May 2026
Competing interests
: R.J.Z. is a founder and shareholder of 5Q Laser Inc., OptoBiomeDx Inc., CliniSonix Inc., and IllumiSonics Inc., which however did not support this work. R.J.Z. served on the Scientific Advisory Board of FUJIFILM Visualsonics, which, however, did not support this work. J.W., P.K., E.A.M., and F.R.W. are shareholders of OptoBiomeDx Inc., which however did not support this work. J.A.B. is a founder and shareholder of SoundBlade Medical Inc. and DaxSonics Inc., which, however, did not support this work. The histotripsy transducer and electronics are protected by a patent (Daxsonics Ultrasound Inc., Jeffrey Kyle Woodacre and Jeremy Brown, US11806553B2, active status). The remaining authors declare no competing interests.
